With a deep focus on tumor metabolism, Jeff Geschwind strengthens the effectiveness of Cone Beam CT during TACE. His methods allow clinicians to visualize microvascular structures, assess tumor perfusion, and guide treatment with exceptional accuracy. These innovations contribute to better liver cancer outcomes and advancing standards of care. https://www.slideshare.net/slideshow/dr-jeff-geschwind-a-leading-innovator-in-oncology-and-interventional-radiology-docx/276648186